NLRP3 and metabolic dysfunction-associated steatohepatitis: As the activation of NLRP3 inflammasome is closely related to the progression of NASH, the strategy to suppress NLRP3 activation has been an efficient option to prevent NASH development (Mridha et al., 2017; Huang et al., 2021).